85th Legislative Session _ 2010

Committee: Senate Health and Human Services
Monday, February 01, 2010

                                            P - Present
                                            E - Excused
                                            A - Absent

Roll Call
P    Dempster
P    Gant
P    Hansen (Tom), Vice-Chair
P    Jerstad
P    Merchant
E    Miles
P    Adelstein, Chair

OTHERS PRESENT: See Original Minutes

The meeting was called to order by Senator Stanford Adelstein, Chair.

MOTION:    TO APPROVE THE MINUTES OF WEDNESDAY, JANUARY 27, 2010

Moved by:    Dempster
Second by:    Gant
Action:    Prevailed by voice vote.

        SB 74: repeal the prohibition against stem cell treatments and research and to establish ethical guidelines to regulate stem cell research.

Presented by:    Senator Ben Nesselhuf (Handouts: Handout:1,2)
Proponents:    Dr. Doris Taylor, Self, Minnespolis, Minnesota, Teleconference
        Jacob Bly, Self, Pierre
        Patricia Brooks, National MS Society, Sioux Falls
        Ryan Green, Self, Sioux Falls
        Dorothy Brewick, Self, Rapid City
Opponents:    Dr. Theresa Deisher, Self, Seattle, WA, Teleconference
        Chris Hupke, SD Family Policy Council (Handouts: Handout 3,4)
        Rita Houglum, Eagle Forum


        Linda Schauer, Concerned Women For America
        George Dummann, SD Right to Life, Pierre (Handouts: Handout 5)
        Deb Fischer Clemens, Avera Health
        Dena Espenscheid, Self, Sioux Falls

MOTION:    AMEND SB 74

74ja

    On the printed bill, delete everything after the enacting clause and insert:

    "    Section 1. That chapter 34-14 be amended by adding thereto a NEW SECTION to read as follows:

    Nothing in this chapter prohibits the use of any Food and Drug Administration approved treatments derived from or involving human embryonic stem cells."


Moved by:    Merchant
Second by:    Dempster
Action:    Failed by roll call vote. (3-3-1-0)

Voting Yes:    Dempster, Hansen (Tom), Adelstein

Voting No:    Gant, Jerstad, Merchant

Excused:    Miles

MOTION:    RECONSIDER SB 74 AMENDMENT

Moved by:    Dempster
Second by:    Merchant
Action:    Prevailed by roll call vote. (4-2-1-0)

Voting Yes:    Dempster, Jerstad, Merchant, Adelstein

Voting No:    Gant, Hansen (Tom)

Excused:    Miles

MOTION:    AMEND SB 74

74ja

    On the printed bill, delete everything after the enacting clause and insert:

    "    Section 1. That chapter 34-14 be amended by adding thereto a NEW SECTION to read as follows:

    Nothing in this chapter prohibits the use of any Food and Drug Administration approved treatments derived from or involving human embryonic stem cells."


Moved by:    Merchant
Second by:    Dempster
Action:    Prevailed by roll call vote. (4-2-1-0)

Voting Yes:    Dempster, Jerstad, Merchant, Adelstein

Voting No:    Gant, Hansen (Tom)

Excused:    Miles

MOTION:    AMEND TITLE OF SB 74

74jta

    On page 1, line 1, of the printed bill, delete everything after "to" and insert "clarify the use of treatments involving human embryonic stem cells.".

    On page 1, delete line 2.


Moved by:    Dempster
Second by:    Jerstad
Action:    Prevailed by voice vote.

MOTION:    DO PASS SB 74 AS AMENDED

Moved by:    Dempster
Second by:    Jerstad
Action:    Prevailed by roll call vote. (4-2-1-0)

Voting Yes:    Dempster, Jerstad, Merchant, Adelstein

Voting No:    Gant, Hansen (Tom)

Excused:    Miles

        THE CHAIR DEFERRED SB 83 UNTIL WEDNESDAY, FEBRUARY 3, 2010

        THE CHAIR DEFERRED SB 92 UNTIL WEDNESDAY, FEBRUARY 3, 2010

MOTION:    ADJOURN

Moved by:    Hansen (Tom)
Second by:    Merchant
Action:    Prevailed by voice vote.

Cindy Louder

____________________________

Committee Secretary
Stanford M. Adelstein, Chair


../02010745.SHE
Page 1